Page 2 - Pharma Stocks

Pharma shares trade firm; Laurus up 2%, Sun Pharma nears 52-week high

Sun Pharma, Cipla, Natco, Dr Reddy's, Torrent Pharma, Aurobindo Pharma and Strides have launched a generic version of Molnupiravir in India post approval for emergency use authorisation from DCGI

Stocks to Watch: Textiles, Amara Raja, Airtel, TCS, ITC, Ajanta Pharma

Textiles shares shall be in limelight as the government has released the operational guidelines for the production-linked incentive (PLI) scheme

Ajanta Pharma gains 5% on share buyback plan, board to meet on Dec 28

The board of directors of the company is scheduled to consider a proposal for buy-back of equity shares on Tuesday, December 28.

Eris Lifesciences soars 10% on JV with MJ Biopharm to enter insulin segment

The purpose of entering into the agreement is expansion of product portfolio to offer biotherapeutic options to the patients in cardio-metabolic segment, Eris said in statement

Unichem Labs surges 15% on ANDA nod from USFDA for Aripiprazole tablets

Aripiprazole tablets are indicated for Schizophrenia and Irritability associated with Autistic Disorder

Glenmark, Alembic, Cipla: Pharma stocks on a booster dose this December

Select pharma stocks look good on the technical charts and may jump up to 15 per cent in December. On the fundamental side, fears of Omicron variant spreading may also keep them in news and buzzing

Stocks to Watch: Reliance, ITC, Paytm, BoB, FMCG, pharma, airline stocks

FMCG stocks are likely to be in focus on the back of price hike announced, while airline shares too may be on investor's radar following the fresh world-wide Coivd-19 scare

Brokerages are betting on pharma stocks with India focus: Analysts

While domestic growth is pegged at double digits, recovery in the US may take a couple of quarters

Pharma stocks rally on buzz about new Covid variant, travel stocks sink

Huge gains for Cipla, Alkem Labs and Dr Lal Path, even as IndiGo, Chalet Hotels and IHC tank

Market wrap: Sensex sinks 1,688 pts, Nifty holds 17K; Rs 7.5-trn investor wealth lost

Pharma stocks soar as investors turn to defensive bets; dollar index inches towards 97 mark

BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%

The pharma index had taken a breather over the past three months after displaying relative out-performance during CY20-21.

GSK Pharma surges 11%, hits 52-week high on improved outlook

The management expects this positive momentum to continue through the second half of the year driving the company towards the better end of a meaningful performance improvement.

Lyka Labs hits 5% upper circuit after Ipca buys 1 mn shares via bulk deals

On Monday, Ipca Laboratories purchased 1.05 million equity shares representing 3.65 per cent stake in Lyka Labs at price of Rs 123 per share on the BSE via bulk deals

Strides Pharma hits 52-week low, slumps 9% on weak Q2 results

The management said a muted sales performance accompanied with a drop in gross margins and relatively higher operating costs has led to a negative operating leverage in H1

Pharma funds lag sectoral peers despite Covid tailwind as US market weighs

In the year to date, the Nifty pharma index has returned 8.8 per cent, with 10 of its constituents giving negative returns

Pharma shares under pressure; Aurobindo, Wockhardt, Hikal, Natco down 6%

Natco Pharma said that a US District Court has issued a decision in favour of Pharmacyclics (a subsidiary of AbbVie), the brand owner of Imbruvica in a PIV litigation involving the product..

Aurobindo Pharma hits 52-week low, slips 25% in one month

The stock of the pharmaceutical company was trading at its lowest level since June 2020

Pharma shares in focus; Alkem, Divi's Lab, Syngene hit record highs

Thus far in the financial year 2021-22 (FY22), the S&P BSE Healthcare index has rallied 24 per cent, as against 9 per cent gain in the S&P BSE Sensex

Natco Pharma slips 6% as Delhi HC allows injunction application by FMC Corp

The Hon'ble High Court of Delhi today orally pronounced judgment in the interim injunction application filed by FMC Corporation on CTPR

Markets log first gain in 5 days; financial, pharma stocks take charge

After a range-bound trading through the day, the BSE Sensex ended 166.07 points or 0.32 per cent higher at 52,484.67